Literature DB >> 20504091

What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma.

Maria Belen Perez Lana1, Vanesa Straminsky, Claudia Onetto, Juliana Martinez Amuchastegui, Georgina Blanco, Liliana Galluzzo, Sergio Provenzano, Manuel Nolting.   

Abstract

OBJECTIVE: To determine if there is a relation between the follicle-stimulating hormone (FSH) and oestradiol levels with values found in bone mineral density, at lumbar spinal and femoral neck levels, in patients with spontaneous premature ovarian failure (POF) as at the time of diagnosis.
METHOD: Cross-sectional study. Eighty-five patients were selected with a diagnosis of POF. Inclusion criteria. Forty women with bone mineral density (BMD) in any of the regions, that is, lumbar spine column or femoral neck. Forty-two age-matched healthy women were included as controls.
RESULTS: The average FSH value found was 80.11 mUI/ml, while the oestradiol average value was 37.2 pg/ml. The FSH values were correlated with the BMD values at the lumbar spinal column (p < 0.002) and the femoral neck (p < 0.002). The oestradiol values did not bear any relation with the BMD values in L2-L4 (p = 0.420) nor with the femoral neck (p = 0.868).
CONCLUSIONS: High FSH concentrations, but not oestradiol, are positively associated with bone mass loss in both skeletal regions, in patients with spontaneous POF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504091     DOI: 10.3109/09513590.2010.487599

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

1.  Estrogen deficiency aggravates apical periodontitis by regulating NLRP3/caspase-1/IL-1β axis.

Authors:  Xiaoyue Guan; Yonghui Guan; Chen Shi; Ximei Zhu; Yani He; Zhichen Wei; Jianmin Yang; Tiezhou Hou
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

Review 2.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

3.  Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats.

Authors:  Jiabin Liu; Haiying Zhang; Yun Zhang; Nan Li; Yuku Wen; Fanglei Cao; Hao Ai; Xiaoou Xue
Journal:  Mol Cells       Date:  2014-11-10       Impact factor: 5.034

4.  Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice.

Authors:  Sook Young Yoon; Jung Ah Yoon; Mira Park; Eun-Young Shin; Sookyung Jung; Jeoung Eun Lee; Jin Hee Eum; Haengseok Song; Dong Ryul Lee; Woo Sik Lee; Sang Woo Lyu
Journal:  Stem Cell Res Ther       Date:  2020-06-26       Impact factor: 6.832

Review 5.  Premature ovarian insufficiency: the context of long-term effects.

Authors:  A Podfigurna-Stopa; A Czyzyk; M Grymowicz; R Smolarczyk; K Katulski; K Czajkowski; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2016-04-18       Impact factor: 4.256

6.  Endometrial mesenchymal stem cells isolated from menstrual blood repaired epirubicin-induced damage to human ovarian granulosa cells by inhibiting the expression of Gadd45b in cell cycle pathway.

Authors:  Zhongrui Yan; Fengyi Guo; Qing Yuan; Yu Shao; Yedan Zhang; Huiyan Wang; Shaohua Hao; Xue Du
Journal:  Stem Cell Res Ther       Date:  2019-01-03       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.